SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,404 | -44.7% | 32,350 | +19.8% | 0.00% | – |
| Q2 2023 | $35,100 | -41.7% | 27,000 | -21.1% | 0.00% | – |
| Q1 2023 | $60,192 | -29.2% | 34,200 | +26.3% | 0.00% | – |
| Q4 2022 | $85,034 | -35.6% | 27,081 | +0.3% | 0.00% | – |
| Q3 2022 | $132,000 | -98.3% | 27,000 | -96.2% | 0.00% | -100.0% |
| Q2 2015 | $7,944,000 | -29.3% | 716,300 | 0.0% | 0.00% | -20.0% |
| Q1 2015 | $11,232,000 | +3.1% | 716,300 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $10,895,000 | +31.2% | 716,300 | -6.9% | 0.01% | +25.0% |
| Q3 2014 | $8,302,000 | -43.1% | 769,800 | -19.4% | 0.00% | -33.3% |
| Q2 2014 | $14,589,000 | -26.4% | 955,400 | -12.8% | 0.01% | -33.3% |
| Q1 2014 | $19,817,000 | – | 1,096,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |